Mansukhani Verushka M, Desai Gunjan S, Mouli Sasi, Shirodkar Keval, Shah Rajiv C, Palepu Jagannath
Department of Surgical Oncology, Lilavati Hospital and Research Centre, A 791, Bandra West, Mumbai, 400 050, India.
Indian J Gastroenterol. 2017 Jan;36(1):62-65. doi: 10.1007/s12664-016-0726-0. Epub 2017 Jan 5.
Transduodenal ampullectomy (TDA) is indicated for large ampullary tumors, for presence of dysplasia on endoscopic biopsy, for poor surgical candidates for pancreaticoduodenectomy, and in cases not indicated for endoscopic ampullectomy. Retrospective review of data from 2009 to 2015 revealed 11 patients who underwent TDA. Magnetic resonance imaging cholangiopancreatography (MRI-MRCP), contrast-enhanced computed tomography (CECT) scan, side-viewing endoscopy, and endoscopic ultrasound (EUS) were used for investigating the patients as required. Preoperative biopsy was done in all. Out of the 11 patients, only one had recurrence. Two patients had adenocarcinoma and were treated with pancreaticoduodenectomy. TDA is a safe surgical procedure for treatment of well-selected benign ampullary pathologies. It is also a treatment option for the cases of ampullary adenomas not amenable to endoscopic resection.
经十二指肠壶腹切除术(TDA)适用于较大的壶腹肿瘤、内镜活检存在发育异常、无法耐受胰十二指肠切除术的手术候选者以及不适合内镜下壶腹切除术的病例。回顾性分析2009年至2015年的数据发现,有11例患者接受了TDA。根据需要,使用磁共振胰胆管造影(MRI-MRCP)、增强计算机断层扫描(CECT)、侧视内镜和内镜超声(EUS)对患者进行检查。所有患者均进行了术前活检。11例患者中,只有1例复发。2例患者患有腺癌,接受了胰十二指肠切除术。TDA是治疗精心挑选的良性壶腹病变的安全手术方法。对于不适合内镜切除的壶腹腺瘤病例,它也是一种治疗选择。